Susi Burgalassi

3.2k total citations
87 papers, 2.6k citations indexed

About

Susi Burgalassi is a scholar working on Pharmaceutical Science, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Susi Burgalassi has authored 87 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pharmaceutical Science, 33 papers in Public Health, Environmental and Occupational Health and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Susi Burgalassi's work include Advanced Drug Delivery Systems (35 papers), Ocular Surface and Contact Lens (33 papers) and Advancements in Transdermal Drug Delivery (29 papers). Susi Burgalassi is often cited by papers focused on Advanced Drug Delivery Systems (35 papers), Ocular Surface and Contact Lens (33 papers) and Advancements in Transdermal Drug Delivery (29 papers). Susi Burgalassi collaborates with scholars based in Italy, New Zealand and United Kingdom. Susi Burgalassi's co-authors include Patrizia Chetoni, M.F. Saettone, Daniela Monti, Silvia Tampucci, Roberta Cavalli, Enrico Boldrini, Maria Rosa Gasco, Ylenia Zambito, Giacomo Di Colo and Luisa Panichi and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Chemistry - A European Journal and Molecules.

In The Last Decade

Susi Burgalassi

82 papers receiving 2.5k citations

Peers

Susi Burgalassi

PHEOH

RNMI

Patrizia Chetoni Italy

Daniela Monti Italy

Cristina Padula Italy

M.F. Saettone Italy

Hamdy Abdelkader Egypt

M.A. Egea Spain

Mohamed A. El-Nabarawi Egypt

Nahed D. Mortada Egypt

Silvia Pescina Italy

Samar Mansour Egypt

Patrizia Chetoni Italy

Susi Burgalassi

1.9k ×1.3

1.0k ×1.3

PHEOH

613 ×1.3

337 ×1.1

360 ×1.2

RNMI

Citations per year, relative to Susi Burgalassi Susi Burgalassi (= 1×) peers Patrizia Chetoni

Countries citing papers authored by Susi Burgalassi

Since Specialization

Citations

This map shows the geographic impact of Susi Burgalassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susi Burgalassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susi Burgalassi more than expected).

Fields of papers citing papers by Susi Burgalassi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susi Burgalassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susi Burgalassi. The network helps show where Susi Burgalassi may publish in the future.

Co-authorship network of co-authors of Susi Burgalassi

This figure shows the co-authorship network connecting the top 25 collaborators of Susi Burgalassi. A scholar is included among the top collaborators of Susi Burgalassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susi Burgalassi. Susi Burgalassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tampucci, Silvia, Patrizia Chetoni, Susi Burgalassi, et al.. (2025). Nanostructured Strategies for Melanoma Treatment—Part I: Design and Optimization of Curcumin-Loaded Micelles for Enhanced Anticancer Activity. Pharmaceuticals. 18(3). 327–327. 3 indexed citations

Pittella, Frederico, Guilherme Diniz Tavares, Adny Henrique Silva, et al.. (2024). Novel natural lipids based NLC containing finasteride improved androgenetic alopecia treatment in rats. International Journal of Pharmaceutics. 666. 124804–124804. 3 indexed citations

Chetoni, Patrizia, et al.. (2024). Nanomicellar eye drops: a review of recent advances. Expert Opinion on Drug Delivery. 21(3). 381–397. 5 indexed citations

Monti, Daniela, et al.. (2023). A comparison between the effects of two liposome-encapsulated bevacizumab formulations on ocular neovascularization inhibition. Colloids and Surfaces B Biointerfaces. 234. 113708–113708. 3 indexed citations

Chetoni, Patrizia, Susi Burgalassi, Carlotta Granchi, et al.. (2022). MAGL inhibitor NanoMicellar formulation (MAGL-NanoMicellar) for the development of an antiglaucoma eye drop. International Journal of Pharmaceutics. 625. 122078–122078. 4 indexed citations

Tampucci, Silvia, et al.. (2021). Combination of Nanomicellar Technology and In Situ Gelling Polymer as Ocular Drug Delivery System (ODDS) for Cyclosporine-A. Pharmaceutics. 13(2). 192–192. 26 indexed citations

Burgalassi, Susi, et al.. (2021). Ocular Application of Oleuropein in Dry Eye Treatment: Formulation Studies and Biological Evaluation. Pharmaceuticals. 14(11). 1151–1151. 5 indexed citations

El‐Kamel, Amal H., et al.. (2021). Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy. International Journal of Nanomedicine. Volume 16. 4481–4494. 61 indexed citations

Tampucci, Silvia, et al.. (2020). Formulations Based on Natural Ingredients for the Treatment of Nail Diseases. Current Pharmaceutical Design. 26(5). 556–565. 6 indexed citations

10.

Monti, Daniela, et al.. (2016). Ionic liquids as potential enhancers for transdermal drug delivery. International Journal of Pharmaceutics. 516(1-2). 45–51. 104 indexed citations

11.

Manera, Clementina, Andrea Chicca, Simone Bertini, et al.. (2015). Development of an HPLC/UV assay for the evaluation of inhibitors of human recombinant monoacylglycerol lipase. Journal of Pharmaceutical and Biomedical Analysis. 108. 113–121. 7 indexed citations

12.

Burgalassi, Susi, et al.. (2007). Larch Arabinogalactan for Dry Eye Protection and Treatment of Corneal Lesions: Investigations in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 23(6). 541–550. 22 indexed citations

13.

Monti, Daniela, et al.. (2005). In Vitro Transungual Permeation of Ciclopirox from a Hydroxypropyl Chitosan-Based, Water-Soluble Nail Lacquer. Drug Development and Industrial Pharmacy. 31(1). 11–17. 63 indexed citations

14.

Burgalassi, Susi, et al.. (2004). Development of Cultured Rabbit Corneal Epithelium for Drug Permeation Studies: A Comparison with Excised Rabbit Cornea. Journal of Ocular Pharmacology and Therapeutics. 20(6). 518–532. 15 indexed citations

15.

Chetoni, Patrizia, et al.. (2004). Comparison of Liposome-Encapsulated Acyclovir with Acyclovir Ointment: Ocular Pharmacokinetics in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 20(2). 169–177. 46 indexed citations

16.

Huhtala, Anne, Susi Burgalassi, Patrizia Chetoni, et al.. (2003). A Collaborative Evaluation of the Cytotoxicity of Two Surfactants by Using the Human Corneal Epithelial Cell Line and the WST-1 Test. Journal of Ocular Pharmacology and Therapeutics. 19(1). 11–21. 19 indexed citations

17.

Colo, Giacomo Di, Ylenia Zambito, Susi Burgalassi, Andrea Serafini, & M.F. Saettone. (2002). Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). International Journal of Pharmaceutics. 248(1-2). 115–122. 57 indexed citations

18.

Burgalassi, Susi, et al.. (1997). Eel skin as a model substrate for mucoadhesion studies. CINECA IRIS Institutial research information system (University of Pisa). 2 indexed citations

19.

Burgalassi, Susi, Patrizia Chetoni, & M.F. Saettone. (1996). Hydrogels for ocular delivery of pilocarpine: Preliminary evaluation in rabbits of the influence of viscosity and of drug solubility. European Journal of Pharmaceutics and Biopharmaceutics. 42(6). 385–392. 17 indexed citations

20.

Burgalassi, Susi, et al.. (1989). Preparation and Evaluation in Rabbits of Topical Solutions Containing Forskolin. Journal of Ocular Pharmacology and Therapeutics. 5(2). 111–118. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact